Table 3 |
||||
|
Comparison of gene amplification analysis and immunohistochemical results of HER-2/neu in 47 cases of ESCC |
||||
|
IHC c-erbB-2 |
FISH HER-2 |
|||
|
|
||||
|
Not Amplified (%) |
Polysomy 17 (%) |
Amplified (%) |
Total |
|
|
|
||||
|
0/1+ |
10 (30.3) |
1 (20) |
0 (0) |
11 |
|
|
||||
|
2+ |
13 (39.4) |
2 (40) |
0 (0) |
15 |
|
|
||||
|
3+ |
4 (12.1) |
2 (40) |
6 (66.7) |
12 |
|
|
||||
|
NA |
6 (18.2) |
0 (0) |
3 (33.3) |
9 |
|
|
||||
|
Total |
33 (100) |
5 (100) |
9 (100) |
47 |
|
|
||||
|
NA: not available |
||||
|
Sato-Kuwabara et al. BMC Cancer 2009 9:6 doi:10.1186/1471-2407-9-6 |
||||
